Donna Roscoe

632 total citations
4 papers, 149 citations indexed

About

Donna Roscoe is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Donna Roscoe has authored 4 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pediatrics, Perinatology and Child Health, 2 papers in Public Health, Environmental and Occupational Health and 2 papers in Genetics. Recurrent topics in Donna Roscoe's work include Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Genomics and Rare Diseases (1 paper). Donna Roscoe is often cited by papers focused on Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Genomics and Rare Diseases (1 paper). Donna Roscoe collaborates with scholars based in United States and Finland. Donna Roscoe's co-authors include Reena Philip, Yuan Li Shen, Emily Y. Jen, Rajeshwari Sridhara, Ann T. Farrell, Richard Pazdur, Aaron J. Schetter, Donna Przepiorka, Albert Deisseroth and Yun‐Fu Hu and has published in prestigious journals such as Clinical Cancer Research, BMC Genomics and Expert Review of Molecular Diagnostics.

In The Last Decade

Donna Roscoe

4 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna Roscoe United States	4	82	42	36	28	27	4	149
Martina Sersch China	7	154 1.9×	73 1.7×	16 0.4×	29 1.0×	8 0.3×	13	182
Stefano Vergani United States	9	38 0.5×	59 1.4×	27 0.8×	125 4.5×	7 0.3×	19	202
Chiara Pavoni Italy	7	33 0.4×	31 0.7×	11 0.3×	18 0.6×	19 0.7×	18	117
Mays Jawad United Kingdom	8	35 0.4×	109 2.6×	32 0.9×	22 0.8×	30 1.1×	13	187
Minilik Angagaw United States	5	31 0.4×	84 2.0×	26 0.7×	14 0.5×	9 0.3×	7	159
Lester Lledo United States	8	126 1.5×	29 0.7×	10 0.3×	43 1.5×	8 0.3×	8	149
Anna Wakulińska Poland	7	30 0.4×	91 2.2×	12 0.3×	58 2.1×	35 1.3×	10	163
Andrea Grioni Czechia	7	24 0.3×	47 1.1×	15 0.4×	41 1.5×	24 0.9×	10	151
Tobias Roider Germany	8	62 0.8×	67 1.6×	8 0.2×	79 2.8×	6 0.2×	19	175
Ian Lewis United Kingdom	6	57 0.7×	50 1.2×	18 0.5×	31 1.1×	16 0.6×	11	141

Countries citing papers authored by Donna Roscoe

Since Specialization

Citations

This map shows the geographic impact of Donna Roscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Roscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Roscoe more than expected).

Fields of papers citing papers by Donna Roscoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Roscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Roscoe. The network helps show where Donna Roscoe may publish in the future.

Co-authorship network of co-authors of Donna Roscoe

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Roscoe. A scholar is included among the top collaborators of Donna Roscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Roscoe. Donna Roscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Horne, Hisani N., Donna Roscoe, E. David Litwack, et al.. (2019). Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop—Workshop Proceedings. JCO Precision Oncology. 3(3). 1–7. 5 indexed citations

2.

Jen, Emily Y., Aaron J. Schetter, Donna Przepiorka, et al.. (2018). FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease. Clinical Cancer Research. 25(2). 473–477. 98 indexed citations

3.

Roscoe, Donna, Yun‐Fu Hu, & Reena Philip. (2015). Companion diagnostics: a regulatory perspective from the last 5 years of molecular companion diagnostic approvals. Expert Review of Molecular Diagnostics. 15(7). 869–880. 15 indexed citations

4.

Han, Tao, Ching‐Wei Chang, Joshua C. Kwekel, et al.. (2012). Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development. BMC Genomics. 13(1). 217–217. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact